|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20060160181A1
(en)
*
|
2000-02-15 |
2006-07-20 |
Amgen Inc. |
Fibroblast Growth Factor-23 molecules and uses thereof
|
|
AU2001249125A1
(en)
*
|
2000-03-08 |
2001-09-17 |
Chiron Corporation |
Human fgf-23 gene and gene expression products
|
|
ES2344679T3
(es)
*
|
2000-08-11 |
2010-09-03 |
Kyowa Hakko Kirin Co., Ltd. |
Polipeptidos que controlan el metabolismo del acido fosforico, el metabolismo del calcio, el metabolismo de la calcificacion y de la vitamina d y moleculas de adn que los codifican.
|
|
US6838264B2
(en)
|
2000-12-05 |
2005-01-04 |
Immutopics, Inc. |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
US7226749B2
(en)
|
2000-12-05 |
2007-06-05 |
Zahradnik Richard J |
Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
|
|
CN1269960C
(zh)
*
|
2000-12-26 |
2006-08-16 |
中外制药株式会社 |
降低血磷水平的人fgf23蛋白质突变体
|
|
EP1381683A2
(en)
*
|
2001-04-26 |
2004-01-21 |
Geneprot, Inc. |
Human fibroblast growth factor-related compositions
|
|
CN100519584C
(zh)
*
|
2001-12-28 |
2009-07-29 |
麒麟医药株式会社 |
抗成纤维细胞生长因子23的抗体
|
|
US7094551B2
(en)
|
2002-09-17 |
2006-08-22 |
Zahradnik Richard J |
Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
|
|
JP5118851B2
(ja)
*
|
2003-11-07 |
2013-01-16 |
ノバルティス アーゲー |
線維芽細胞増殖因子フラグメントの使用
|
|
WO2005108607A1
(en)
*
|
2004-05-09 |
2005-11-17 |
Technion Research & Development Foundation Ltd. |
Compositions and methods for treating disorders associated with abnormal phosphate metabolism
|
|
IL161886A0
(en)
*
|
2004-05-09 |
2005-11-20 |
Technion Res & Dev Foundation |
Development of inducers of udp-n-acetyl-alphad-galactosamine: polypeptide n-acetylgalactosami-nyltransferase 3(ppgantase
|
|
EP1904933A4
(en)
*
|
2005-04-18 |
2009-12-09 |
Clearplay Inc |
DEVICE, SYSTEM AND METHOD FOR ASSOCIATING ONE OR MORE FILTER FILES WITH A PARTICULAR MULTIMEDIA PRESENTATION
|
|
KR100760525B1
(ko)
*
|
2006-04-13 |
2007-10-04 |
김재만 |
병원성 미생물의 무증폭 다중 정량 검출킷트 및 검출방법
|
|
US8012694B2
(en)
|
2006-09-14 |
2011-09-06 |
Immutopics, Inc. |
Assay for the detection of phosphorylated PTH
|
|
EP2468888B1
(en)
*
|
2007-01-22 |
2018-04-11 |
Medizinische Universität Innsbruck |
Novel markers for chronic kidney disease
|
|
US7883705B2
(en)
*
|
2007-02-14 |
2011-02-08 |
Kyowa Hakko Kirin Co., Ltd. |
Anti FGF23 antibody and a pharmaceutical composition comprising the same
|
|
WO2009091556A2
(en)
*
|
2008-01-17 |
2009-07-23 |
The General Hospital Corporation |
Diagnostic methods and kits using fibroblast growth factor-23
|
|
TW200936156A
(en)
|
2008-01-28 |
2009-09-01 |
Novartis Ag |
Methods and compositions using Klotho-FGF fusion polypeptides
|
|
US8420088B2
(en)
*
|
2008-01-28 |
2013-04-16 |
Novartis Ag |
Methods and compositions using FGF23 fusion polypeptides
|
|
CN103353532B
(zh)
*
|
2008-04-29 |
2016-05-11 |
诺瓦提斯公司 |
监测成纤维细胞生长因子受体的激酶活性的调节的方法及所述方法的应用
|
|
US8889621B2
(en)
*
|
2009-10-30 |
2014-11-18 |
New York University |
Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia
|
|
US20110195077A1
(en)
*
|
2010-01-29 |
2011-08-11 |
Novartis Ag |
Methods and compositions using fgf23 fusion ppolypeptides
|
|
WO2012029837A1
(ja)
|
2010-08-31 |
2012-03-08 |
協和メデックス株式会社 |
線維芽細胞増殖因子－２３の測定方法及び測定試薬
|
|
WO2012055096A1
(zh)
*
|
2010-10-27 |
2012-05-03 |
温州医学院生物与天然药物开发中心有限公司 |
抗fgf-23抗体的制备方法及用途
|
|
US20140294820A1
(en)
|
2011-06-24 |
2014-10-02 |
University Of Miami |
Fibroblast growth factor receptor inhibition for the treatment of disease
|
|
LT2726511T
(lt)
|
2011-07-01 |
2019-11-11 |
Ngm Biopharmaceuticals Inc |
Kompozicijos, panaudojimai ir būdai, skirti metabolinių sutrikimų ir ligų gydymui
|
|
WO2013027191A1
(en)
|
2011-08-25 |
2013-02-28 |
Novartis Ag |
Methods and compositions using fgf23 fusion polypeptides
|
|
US9657075B2
(en)
|
2012-06-07 |
2017-05-23 |
New York University |
Chimeric fibroblast growth factor 23 proteins and methods of use
|
|
AU2013352363B2
(en)
|
2012-11-28 |
2018-04-12 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods for treatment of metabolic disorders and diseases
|
|
US9290557B2
(en)
|
2012-11-28 |
2016-03-22 |
Ngm Biopharmaceuticals, Inc. |
Compositions comprising variants and fusions of FGF19 polypeptides
|
|
US9273107B2
(en)
|
2012-12-27 |
2016-03-01 |
Ngm Biopharmaceuticals, Inc. |
Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
AU2013370404B2
(en)
|
2012-12-27 |
2017-11-02 |
Ngm Biopharmaceuticals, Inc. |
Methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
US9550820B2
(en)
|
2013-02-22 |
2017-01-24 |
New York University |
Chimeric fibroblast growth factor 23/fibroblast growth factor 19 proteins and methods of use
|
|
JP6479775B2
(ja)
*
|
2013-09-20 |
2019-03-06 |
ロンザ リミテッドＬｏｎｚａ Ｌｉｍｉｔｅｄ |
細胞の核リプログラミングのための方法
|
|
MX377380B
(es)
|
2013-10-28 |
2025-03-10 |
Ngm Biopharmaceuticals Inc |
Modelos de cáncer y métodos asociados.
|
|
SI3097122T1
(sl)
|
2014-01-24 |
2020-07-31 |
Ngm Biopharmaceuticals, Inc. |
Protitelesa, ki se vežejo v domeni beta klotho 2, in metode za njihovo uporabo
|
|
US10464979B2
(en)
|
2014-03-28 |
2019-11-05 |
New York University |
FGF23 c-tail fusion proteins
|
|
WO2015183890A2
(en)
|
2014-05-28 |
2015-12-03 |
Ngm Biopharmaceuticals, Inc. |
Methods and compositions for the treatment of metabolic disorders and diseases
|
|
AU2015275128C1
(en)
|
2014-06-09 |
2020-02-13 |
Kyowa Kirin Co., Ltd. |
The effective and efficient control of serum phosphate for optimal bone formation
|
|
EP3155005A4
(en)
|
2014-06-16 |
2018-07-11 |
NGM Biopharmaceuticals, Inc. |
Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
|
|
UA123763C2
(uk)
|
2014-10-23 |
2021-06-02 |
Енджіем Байофармасьютикалз, Інк. |
Фармацевтична композиція для контролю або лікування захворювання або порушення, пов’язаного з fgf19
|
|
US10434144B2
(en)
|
2014-11-07 |
2019-10-08 |
Ngm Biopharmaceuticals, Inc. |
Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders
|
|
CN107810201A
(zh)
|
2014-12-04 |
2018-03-16 |
诺华股份有限公司 |
使用klotho变体多肽的方法和组合物
|
|
CN105699664A
(zh)
*
|
2015-04-13 |
2016-06-22 |
陈柏龄 |
Fgf23检测试剂盒及其制备方法
|
|
AU2016284696B2
(en)
*
|
2015-06-25 |
2021-10-28 |
Amyris, Inc. |
Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
|
|
WO2017019957A2
(en)
|
2015-07-29 |
2017-02-02 |
Ngm Biopharmaceuticals, Inc. |
Binding proteins and methods of use thereof
|
|
CA3003616C
(en)
|
2015-11-09 |
2020-07-28 |
Ngm Biopharmaceuticals, Inc. |
Methods for treatment of bile acid-related disorders
|
|
CA3034399A1
(en)
|
2016-08-26 |
2018-03-01 |
Ngm Biopharmaceuticals, Inc. |
Methods of treating fibroblast growth factor 19-mediated cancers and tumors
|
|
JP7181534B2
(ja)
*
|
2017-03-28 |
2022-12-01 |
味の素株式会社 |
未分化維持培地添加剤
|
|
JP7296875B2
(ja)
|
2017-05-31 |
2023-06-23 |
ミナリスメディカル株式会社 |
線維芽細胞増殖因子－２３の測定方法、測定試薬及び測定キット
|
|
WO2020047475A1
(en)
*
|
2018-08-30 |
2020-03-05 |
The Uab Research Foundation |
Drug screening for fgf23-fgfr4 inhibitors
|
|
SG11202110732XA
(en)
*
|
2019-03-29 |
2021-10-28 |
Atarga Llc |
Anti fgf23 antibody
|
|
EP3956354A1
(en)
*
|
2019-04-19 |
2022-02-23 |
Genethon |
Gene therapy of fibroblast growth factor 23 related hypophosphatemic diseases
|